Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09

Ocata Therapeutics (NASDAQ: OCAT) reported Q3 EPS of ($0.09), versus ($0.13) reported last year.

For earnings history and earnings-related data on Ocata Therapeutics (OCAT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• UBS says bull market has further to run